TLDR Powell’s speech may confirm two additional rate cuts, impacting the USD. Markets expect 25 basis-point rate cuts in October and December. Mixed Fed views on inflation and labor market risks could influence policy. Powell’s cautious stance could support the U.S. dollar despite rate cuts. Federal Reserve Chair Jerome Powell is set to speak on [...] The post Powell’s Upcoming Speech Could Confirm Two More Fed Rate Cuts This Year appeared first on CoinCentral.TLDR Powell’s speech may confirm two additional rate cuts, impacting the USD. Markets expect 25 basis-point rate cuts in October and December. Mixed Fed views on inflation and labor market risks could influence policy. Powell’s cautious stance could support the U.S. dollar despite rate cuts. Federal Reserve Chair Jerome Powell is set to speak on [...] The post Powell’s Upcoming Speech Could Confirm Two More Fed Rate Cuts This Year appeared first on CoinCentral.

Powell’s Upcoming Speech Could Confirm Two More Fed Rate Cuts This Year

2025/10/14 21:32
4 min read
For feedback or concerns regarding this content, please contact us at [email protected]

TLDR

  • Powell’s speech may confirm two additional rate cuts, impacting the USD.
  • Markets expect 25 basis-point rate cuts in October and December.
  • Mixed Fed views on inflation and labor market risks could influence policy.
  • Powell’s cautious stance could support the U.S. dollar despite rate cuts.

Federal Reserve Chair Jerome Powell is set to speak on the U.S. economic outlook and monetary policy at the NABE Annual Meeting in Philadelphia. His remarks come amid a government shutdown that has delayed key economic data releases, which may have an immediate effect on the U.S. dollar (USD). Market participants are closely watching for any confirmation of the Federal Reserve’s expected actions, including two more rate cuts this year.

Market Expectations for Further Rate Cuts

The CME FedWatch Tool currently shows a 100% probability of a 25 basis-point rate cut in October, with a nearly 90% chance of another rate reduction in December. The anticipation of these cuts has shaped market sentiment, particularly around the U.S. dollar’s performance. While Powell’s speech will not provide new economic data, his comments may offer clues on how the Fed plans to navigate the upcoming months.

Fed officials have provided a variety of views on the path forward. Governor Michael Barr expressed concern about overlooking inflation risks driven by tariffs, stating that these factors could complicate the Fed’s inflation targets. Meanwhile, other officials, such as San Francisco Fed President Mary Daly, have signaled a more dovish stance, noting that inflation has been lower than expected and cautioning that a weakening labor market could pose risks to the broader economy.

Risks to the U.S. Dollar

If Powell indicates a continued easing of monetary policy, particularly in response to a softening labor market, the U.S. dollar could face additional downward pressure. Markets are already pricing in the likelihood of two rate cuts, which typically diminish the appeal of the dollar. However, despite these expectations, the downside for the U.S. dollar appears limited in the short term, given its current positioning in global markets.

On the other hand, if Powell adopts a more cautious tone and signals hesitation in pursuing consecutive rate cuts, it could bolster the U.S. dollar. Many investors are mindful of the uncertainty surrounding key economic data releases and potential trade tensions, particularly with the ongoing risks related to U.S.-China relations. Powell’s comments may help shape expectations for how the Fed balances these uncertainties with its dual mandate of price stability and maximum employment.

Mixed Fed Signals on Economic Outlook

Recent comments from other Federal Reserve officials reflect differing views on how to address economic challenges. St. Louis Fed President Alberto Musalem raised concerns about the potential for inflation expectations to become unanchored if the Fed struggles to respond effectively to short-term fluctuations in the labor market. He emphasized that managing these risks would be key to ensuring sustained economic stability.

In contrast, Philadelphia Fed President Anna Paulson downplayed the role of tariffs in driving long-term inflation, suggesting that their impact would be more limited than some feared. Paulson also acknowledged the growing risks to the labor market but did not expect them to lead to sustained inflationary pressures. These mixed messages point to the uncertainty that Powell will likely address during his upcoming speech.

Powell’s Potential Approach to Rate Cuts

The core question for markets remains whether Powell will confirm the expected rate cuts or suggest a more cautious approach. If Powell acknowledges the possibility of further easing, particularly in response to soft labor market data, it could signal continued weakness for the U.S. dollar. However, if he highlights the ongoing risks from trade conflicts and the lack of key economic data, he may signal that the Fed will be more measured in its decisions.

At this stage, Powell’s comments will be scrutinized for any signs of how the Fed will manage the economic outlook given the uncertainties surrounding inflation and employment. The lack of key data releases due to the government shutdown only adds to the complexity of the decision-making process. As such, Powell’s speech will likely play a crucial role in shaping market expectations for the rest of the year.

The post Powell’s Upcoming Speech Could Confirm Two More Fed Rate Cuts This Year appeared first on CoinCentral.

Market Opportunity
Moonveil Logo
Moonveil Price(MORE)
$0.000454
$0.000454$0.000454
-1.85%
USD
Moonveil (MORE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09